University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital
Search Site | Find a Doctor
Print this page
FONT SIZE
Home > Doctors > John Chung-Kai Chan

John Chung-Kai Chan, M.D.

Gynecologic cancer surgeon

Dr. John K. Chan is director of Gynecologic Oncology and a specialist in the treatment of ovarian and other pelvic cancers at the UCSF Helen Diller Family Comprehensive Cancer Center. As director, Chan oversees the division's activities in patient care, research and education. He also treats patients at UCSF Medical Center at ValleyCare in Pleasanton and Marin General Hospital.

In his research, Chan focuses on new gynecologic cancer treatments including gene therapy, cellular immunotherapy and targeted biologic therapy. These projects have resulted in more than 100 articles and abstracts in journals such as Lancet Oncology, Cancer Research, Journal of Clinical Oncology and multiple book chapters. He is the John A. Kerner Distinguished Professor in Gynecologic Oncology at UCSF and a principal investigator in clinical trials on ovarian cancer. He has received grants from the Ovarian Cancer Research Foundation, Gynecologic Cancer Foundation and UCSF Gynecologic Oncology Group. Chan is on the board of directors of the American Cancer Society Northern California Chinese Unit and is fluent in Chinese (Mandarin and Cantonese) and medical Spanish. Prior to joining UCSF, he was a cancer specialist at the Stanford Cancer Center.

Clinics

Gynecologic Surgical Oncology
1600 Divisadero St., Fourth Floor
San Francisco, CA 94115
Phone: (415) 353-9600
New Patient Fax: (415) 353-7657

Hours: Monday to Friday
8 a.m. – 5 p.m.

Conditions & Treatments

More about John Chung-Kai Chan

Additional Languages

Cantonese
Mandarin
Spanish

Education

UCLA School of Medicine 1995

Residencies

UC Irvine Medical Center 1999

Fellowships

M.D. Anderson Cancer Center, Gynecological Cancer 1999
UC Ivine Medical Center, Gynecological Cancer 2003

Selected Research and Publications

  1. Yu X, Lum D, Kiet TK, Fuh KC, Orr J, Brooks RA, Ueda SM, Chen LM, Kapp DS, Chan JK. Utilization of and charges for robotic versus laparoscopic versus open surgery for endometrial cancer. J Surg Oncol. 2013 May; 107(6):653-8.
  2. Cohen JG, Chan JK, Kapp DS. The management of small-cell carcinomas of the gynecologic tract. Curr Opin Oncol. 2012 Sep; 24(5):572-9.
  3. Cohen JG, Kiet T, Shin JY, Sherman AE, Hamilton CA, Brooks RA, Ueda SM, Chen LM, Kapp DS, Chan JK. Factors associated with publication of plenary presentations at the Society of Gynecologic Oncologists annual meeting. Gynecol Oncol. 2013 Jan; 128(1):128-31.
  4. Cohen JG, Sherman AE, Kiet TK, Kapp DS, Osann K, Chen LM, O'Sullivan PS, Chan JK. Characteristics of success in mentoring and research productivity - a case-control study of academic centers. Gynecol Oncol. 2012 Apr; 125(1):8-13.
  5. Venkat P, Chen LM, Young-Lin N, Kiet TK, Young G, Amatori D, Dasverma B, Yu X, Kapp DS, Chan JK. An economic analysis of robotic versus laparoscopic surgery for endometrial cancer: costs, charges and reimbursements to hospitals and professionals. Gynecol Oncol. 2012 Apr; 125(1):237-40.
  6. Dalton HJ, Yu X, Hu L, Kapp DS, Benjamin I, Monk BJ, Chan JK. An economic analysis of dose dense weekly paclitaxel plus carboplatin versus every-3-week paclitaxel plus carboplatin in the treatment of advanced ovarian cancer. Gynecol Oncol. 2012 Feb; 124(2):199-204.
  7. Chan JK, Sherman AE, Kapp DS, Zhang R, Osann KE, Maxwell L, Chen LM, Deshmukh H. Influence of gynecologic oncologists on the survival of patients with endometrial cancer. J Clin Oncol. 2011 Mar 1; 29(7):832-8.
  8. Monk BJ, Chan JK. American Society of Clinical Oncology 2010 Annual Meeting update: summary of selected gynecologic cancer abstracts. Gynecol Oncol. 2010 Sep; 118(3):216-9.
  9. Cohen JG, Kapp DS, Shin JY, Urban R, Sherman AE, Chen LM, Osann K, Chan JK. Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients. Am J Obstet Gynecol. 2010 Oct; 203(4):347.e1-6.
  10. Chan JK, Tian C, Fleming GF, Monk BJ, Herzog TJ, Kapp DS, Bell J. The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: an exploratory analysis of a Gynecologic Oncology Group study. Gynecol Oncol. 2010 Mar; 116(3):301-6.
  11. Chan JK, Tian C, Teoh D, Monk BJ, Herzog T, Kapp DS, Bell J. Survival after recurrence in early-stage high-risk epithelial ovarian cancer: a Gynecologic Oncology Group study. Gynecol Oncol. 2010 Mar; 116(3):307-11.
  12. Chen LM, Weinberg VK, Chen C, Powell CB, Chen LL, Chan JK, Burkhardt DH. Perioperative outcomes comparing patient controlled epidural versus intravenous analgesia in gynecologic oncology surgery. Gynecol Oncol. 2009 Dec; 115(3):357-61.
  13. Schmid S, Hsu IC, Hu JM, Sherman AE, Osann K, Kapp DS, Chan JK. Adjuvant radiation therapy in stage III node-positive uterine cancer. Gynecol Oncol. 2009 Nov; 115(2):239-43.
  14. Havrilesky LJ, Maxwell GL, Chan JK, Myers ER. Cost effectiveness of a test to detect metastases for endometrial cancer. Gynecol Oncol. 2009 Mar; 112(3):526-30.
  15. Chan JK, Kawar NM, Shin JY, Osann K, Chen LM, Powell CB, Kapp DS. Endometrial stromal sarcoma: a population-based analysis. Br J Cancer. 2008 Oct 21; 99(8):1210-5.
  16. Sugiyama VE, Chan JK, Kapp DS. Management of melanomas of the female genital tract. Curr Opin Oncol. 2008 Sep; 20(5):565-9.
  17. Chan JK, Tewari KS, Waller S, Cheung MK, Shin JY, Osann K, Kapp DS. The influence of conservative surgical practices for malignant ovarian germ cell tumors. J Surg Oncol. 2008 Aug 1; 98(2):111-6.
  18. Chan JK, Tian C, Monk BJ, Herzog T, Kapp DS, Bell J, Young RC. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study. Cancer. 2008 May 15; 112(10):2202-10.
  19. Chan JK, Teoh D, Hu JM, Shin JY, Osann K, Kapp DS. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers. Gynecol Oncol. 2008 Jun; 109(3):370-6.
  20. Chan J, Fuh K, Shin J, Cheung M, Powell C, Chen LM, Kapp D, Osann K. The treatment and outcomes of early-stage epithelial ovarian cancer: have we made any progress? Br J Cancer. 2008 Apr 8; 98(7):1191-6.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions by logging on to UCSF Profiles.

Home • Terms of Use • Site Map • Contact Us       © 2002 - 2013 The Regents of The University of California